1. Home
  2. EBR vs UTHR Comparison

EBR vs UTHR Comparison

Compare EBR & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBR
  • UTHR
  • Stock Information
  • Founded
  • EBR 1962
  • UTHR 1996
  • Country
  • EBR Brazil
  • UTHR United States
  • Employees
  • EBR N/A
  • UTHR N/A
  • Industry
  • EBR Electric Utilities: Central
  • UTHR Biotechnology: Pharmaceutical Preparations
  • Sector
  • EBR Utilities
  • UTHR Health Care
  • Exchange
  • EBR Nasdaq
  • UTHR Nasdaq
  • Market Cap
  • EBR 16.7B
  • UTHR 15.5B
  • IPO Year
  • EBR N/A
  • UTHR 1999
  • Fundamental
  • Price
  • EBR $6.20
  • UTHR $363.25
  • Analyst Decision
  • EBR
  • UTHR Buy
  • Analyst Count
  • EBR 0
  • UTHR 14
  • Target Price
  • EBR N/A
  • UTHR $370.86
  • AVG Volume (30 Days)
  • EBR 1.0M
  • UTHR 389.6K
  • Earning Date
  • EBR 11-07-2024
  • UTHR 10-30-2024
  • Dividend Yield
  • EBR 0.94%
  • UTHR N/A
  • EPS Growth
  • EBR 249.43
  • UTHR 25.10
  • EPS
  • EBR 0.84
  • UTHR 22.72
  • Revenue
  • EBR $6,993,057,205.00
  • UTHR $2,756,200,000.00
  • Revenue This Year
  • EBR $9.43
  • UTHR $26.32
  • Revenue Next Year
  • EBR $3.41
  • UTHR $10.37
  • P/E Ratio
  • EBR $7.46
  • UTHR $15.99
  • Revenue Growth
  • EBR 5.06
  • UTHR 25.04
  • 52 Week Low
  • EBR $6.02
  • UTHR $208.62
  • 52 Week High
  • EBR $9.11
  • UTHR $417.82
  • Technical
  • Relative Strength Index (RSI)
  • EBR 34.55
  • UTHR 42.87
  • Support Level
  • EBR $6.02
  • UTHR $396.52
  • Resistance Level
  • EBR $6.28
  • UTHR $417.82
  • Average True Range (ATR)
  • EBR 0.14
  • UTHR 12.41
  • MACD
  • EBR -0.01
  • UTHR -0.95
  • Stochastic Oscillator
  • EBR 24.31
  • UTHR 26.51

About EBR Centrais Electricas Brasileiras S A (Each representing one Common Share)

Centrais Eletricas Brasileiras SA is engaged in the generation, transmission, and commercialization of electricity in Brazil. The company operates a portfolio of wind, thermal, hydro, and nuclear power plants located throughout the country. Its segments are Generation which consists of the generation of electric energy and the sale of energy to distribution companies and free consumers, and commercialization; Transmission which consists of the transmission of electric energy; and Administration activities mainly represent the Company's cash management, the management of the compulsory loan, and the management of business in SPEs, and others.

About UTHR United Therapeutics Corporation

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

Share on Social Networks: